Contributed articles on semantics philosophy of vedic literature and poetics presented earlier at a seminar honoring Kapil Kapoor, Indian Indologist.

The COVID-19 pandemic resulted in an abrupt change in routines and livelihoods all around the world. This public health crisis amplified a number of systemic inequalities that led to populations needing to grapple with universally difficult truths. Yet some individuals, firms, and countries displayed resilient and creative responses in coping with pressing demands on healthcare and basic sanity. Past work has suggested that engaging in creative acts can be an adaptive response to a changing environment. Therefore, the purpose of this (...) paper is to describe how entities at the personal, community, and national levels cultivated and expressed creativity in an effort to make meaning during COVID-19. By overlaying the Four C model of creativity on such responses, we aim to (a) to connect mini, little, Pro, and Big creative behaviors with our attempts to make meaning of the ongoing COVID-19 pandemic, and (b) to suggest how engaging in creative expression can be used to guard against the adverse consequences of this outbreak. Acknowledging that this time has been and continues to be distressing and filled with uncertainty, we propose some ways of making sense of current events by applying original thinking across domains. Further, we propose how engaging in creativity can serve to buffer against the negative effects of living through the pandemic. (shrink)

This book critically analyzes important current issues in international development-growth, poverty, inequality, participation, consumption, corruption, gender, race, LGBT politics, revolution, universalism-by deploying key psychoanalytic concepts-enjoyment, fantasy, antagonism, fetishism, envy, drive, perversion, hysteria. It draws on the work of Lacan and Žižek, and on psychoanalytic postcolonial and feminist scholarship.

Global Dental Practice Management Software Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Major Companies Focus on Partnerships to Leverage Enhanced Solutions -/- In terms of the competitive landscape, the dental practice management software market has a partial consolidation owing to the large shares held by leading companies. Different strategic moves, including joint ventures, mergers, and acquisitions are being leveraged (...) by prominent companies to reinforce their industry position. A wide array of players are focusing on partnerships to deploy enhanced solutions. -/- Drivers & Restraints -/- The global dental practice management software market size was valued at USD 1.65 billion in 2023. The market is expected to expand from USD 1.80 billion in 2024 to USD 3.90 billion by 2032, exhibiting a CAGR of 10.2% over the study period. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Dental Practice Management Software Market report. -/- This report focuses on Dental Practice Management Software Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dental Practice Management Software Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Dental Practice Management Software Market research report: -/- NXGN Management, LLC (U.S.) Planet DDS (U.S.) ACE Dental Software (U.S.) Datacon Dental Systems (U.S.) Good Methods Global Inc. (U.S.) CD Newco, LLC (U.S.) Henry Schein, Inc (U.S.) Carestream Dental LLC (U.S.) DentiMax (U.S.). (shrink)

Illustrations: 1 B/w Illustration Description: This is a comprehensive, critical and comparative study of all aspects of the philosophy and religion of Sri Caitanya. In the first three chapters the history of the Vaisnava religion is traced from the earliest Vedic period to pre-Caitanya Vaisnavism in Bengal and some controversies regarding the life of Sri Caitanya and the Sampradaya or the sect to which he belongs are set at rest. In the succeeding chapters the problems of philosophy and religion are (...) discussed in detail. It is shown how Sri Caitanya breathes a new spirit into philosophy and religion by transcending the narrow and mutually conflicting 'isms' and dogmas and reconciling them in a higher synthesis by means of the concept of the absolute as Bhagavan and the doctrine of Acintya-bhedabheda or inconceivable identity-indifference. The importance of Bhakti as the exclusive means of attaining God is His highest and sweetest form is stressed. Prema or divine love is distinguished from eroticism and established as the highest end. The doctrine of Rasa or transcendental relish is explained and Parakiya Rasa is established as the highest Rasa. (shrink)

Students display resistance, including academic dishonesty, at all educational levels. In the present study, we qualitatively examined the extent and incidence of academic misbehaviors by 101 US college students. Using a combination of self-reported closed- and open-ended questions, we developed a multi-faceted understanding of how students perceived their own classroom misbehaviors to avoid work as being original, clever, deceptive, and unethical. Questions pertaining to possible prevention, impact on grade, and repetition of the misbehavior were also included. Further, environmental contributors of (...) such behavior were explored, inclusive of the teacher, curriculum, larger school/institutional reasons, peers, and out-of-school issues. Thematic analyses identified distinct themes related to each factor, with poor time management emerging as a salient antecedent across factors. The present study also reviews and provides strategies to improve time management among students to mitigate future instances of academic misbehavior. (shrink)

This article focuses on three recent controversies in which Žižek has been embroiled and for which he has taken positions that rest on the notion of antagonism. His views on Eurocentrism, the European refugee crisis and trans politics have been the subject of notable disapproval, if not denunciation. Critics reproach him for being Eurocentric, racist and transphobic, charges which he has repeatedly countered. The article will examine the differing theoretical and political positions in these debates, underlining what Žižek’s critics miss (...) or misunderstand about his notion of antagonism. While I side firmly with Žižek on the substance of these issues, I nonetheless consider the extent to which at least part of the disagreement here centres on the performative rather than the strictly “theoretical”: Might his critics be reacting to his overexposure? Could such overexposure be interpreted as an attempt at having the last word? And to what extent does the antagonistic form of Žižek’s interventions militate against their theoretical content? (shrink)

Global Cellular Health Screening Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- Also, the growing importance of healthy life expectancy (HALE) and the use of home diagnostic tests are remarkably increasing globally. As a result, there is increasing demand for cellular health screening kits and services due to greater patient (...) awareness. Moreover, home diagnostic tests are convenient for patients because it helps to save time and cost associated with visiting hospitals and clinics. -/- Drivers & Restraints -/- The growing awareness for personalized medicine across the world due to the emergence of new disease conditions increased the rate of clinical studies conducted in countries such as the U.S., the U.K., and China. This led to the adoption of cellular health screening tests for an overview of health at a cellular level. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Cellular Health Screening Market report. -/- This report focuses on Cellular Health Screening Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cellular Health Screening Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Cellular Health Screening Market research report: -/- . (shrink)

The global “diabetes monitoring devices market size” is expected to rise owing to increasing awareness about the self-management of diabetes. Fortune Business Insights in a report, titled “Diabetes Monitoring Devices: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the market, highlighting opportunities and threats alike. The global market is expected to yield huge profits facilitated by remarkable developments in diabetes management. As per the International Diabetes Foundation (IDF), the number of people suffering from diabetes was 415 million (...) in 2015 and is expected to reach 642 million by the year 2040. The rising prevalence of diabetes across the globe is a major factor driving the market. (shrink)

Global In-vitro Diagnostics Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- In vitro Diagnostics (IVD) are medical devices used to perform diagnostic tests on biological samples such as blood, urine, and tissues. The IVD tests help detect and monitor infectious diseases, autoimmune diseases, and several medical conditions that are being (...) used to analyze drug therapies. Furthermore, according to the British In-vitro Diagnostic Association, in vitro diagnostics tests influence approximately 70% of clinical decisions. However, less than 1% of the NHS's budget is spent developing innovative IVD product portfolios each year. -/- Drivers & Restraints -/- The global in-vitro diagnostics market size stood at USD 97.12 Billion in 2023 and is projected to reach USD 157.02 Billion by 2030, exhibiting at a CAGR of 7.1% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this In-vitro Diagnostics Market report. -/- This report focuses on In-vitro Diagnostics Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall In-vitro Diagnostics Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global In-vitro Diagnostics Market research report: -/- F. Hoffmann-La Roche Ltd (Switzerland) Abbott Laboratories (U.S.) Thermo Fisher Scientific Inc. (U.S.) Sysmex Corporation (Japan) Siemens Healthineers AG (Germany) BD (Becton, Dickinson, and Company) (U.S.) Seegene Inc. (Republic of Korea) DiaSorin S.p.A. (Italy) Quest Diagnostics Incorporated (U.S.) Bio-Rad Laboratories, Inc. (U.S.). (shrink)

Global Neuropathic Pain Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. Novartis AG, Pfizer Inc., and Viatris Inc. are some of the leading companies that hold a noteworthy share of the global market. These players focus on enhancing their product portfolio for nerve pain management to strengthen their market positions. In July 2023, Novartis AG procured the U.S.-based, preclinical-stage biotechnology business (...) named DTx Pharma with an objective to improve its R&D to produce siRNA therapeutics for neurology indications. -/- Drivers & Restraints -/- The global neuropathic pain market size was USD 7.37 billion in 2023. The market is expected to surge from USD 7.79 billion in 2024 to USD 14.05 billion by 2032 at a CAGR of 7.7% during 2024-2032. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Neuropathic Pain Market report. -/- This report focuses on Neuropathic Pain Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Neuropathic Pain Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Neuropathic Pain Market research report: -/- Almatica (U.S.) Azurity Pharmaceuticals, Inc. (U.S.) Pfizer Inc. (U.S.) Viatris Inc. (U.S.) Supernus Pharmaceuticals, Inc. (U.S.) Novartis AG (Switzerland) Accord Healthcare (U.K.) Focus Health Group (U.S.) Amneal Pharmaceuticals LLC (U.S.) Abbott (U.S.) Teva Pharmaceutical Industries Ltd. (Israel) Market Share Analysis: -/- The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. (shrink)

Global Stomach Cancer Treatment Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Stomach cancer is the fifth most common cancer in the world. According to Cancer Research U.K., 6,697 gastric carcinoma cases are diagnosed each year. Stomach cancers are classified into three types. Gastric Adenocarcinoma is the most common type of stomach cancer and accounts for 90%-95% of stomach cancer (...) cases. Gastrointestinal Stromal Tumor (GIST) and Gastric Neuroendocrine Tumors (gNET) are rare in nature. Rising incidence of cancer cases and limited drugs as first-line treatment are the major factors that have encouraged many pharmaceutical giants to conduct research for the development of novel drugs. -/- Drivers & Restraints -/- The global stomach cancer treatment market size stood at USD 2.61 Billion in 2018 and is projected to reach USD 8.20 Billion by 2026, exhibiting at a CAGR of 15.3% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Stomach Cancer Treatment Market report. -/- This report focuses on Stomach Cancer Treatment Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Stomach Cancer Treatment Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- . (shrink)

Global Transcatheter Heart Valve Replacement Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- The global transcatheter heart valve replacement (THVR) market size was USD 4.04 billion in 2018 and is projected to reach USD 10.34 billion by 2026, exhibiting a CAGR of 12.5% during the forecast period. -/- Drivers & Restraints -/- The global transcatheter heart valve replacement market size (...) stood at USD 4.04 Billion in 2018 and is projected to reach USD 10.34 Billion by 2026, exhibiting at a CAGR of 12.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Transcatheter Heart Valve Replacement Market report. -/- This report focuses on Transcatheter Heart Valve Replacement Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Heart Valve Replacement Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Transcatheter Heart Valve Replacement Market research report: -/- Edwards Lifesciences Corporation Abbott Medtronic LivaNova PLC Boston Scientific Corporation CryoLife, Inc. Micro Interventional Devices, Inc. (shrink)

Global Transcatheter Heart Valve Replacement Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- The global transcatheter heart valve replacement (THVR) market size was USD 4.04 billion in 2018 and is projected to reach USD 10.34 billion by 2026, exhibiting a CAGR of 12.5% during the forecast period. -/- Drivers & Restraints -/- The global transcatheter heart valve replacement market size (...) stood at USD 4.04 Billion in 2018 and is projected to reach USD 10.34 Billion by 2026, exhibiting at a CAGR of 12.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Transcatheter Heart Valve Replacement Market report. -/- This report focuses on Transcatheter Heart Valve Replacement Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Heart Valve Replacement Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Transcatheter Heart Valve Replacement Market research report: -/- Edwards Lifesciences Corporation Abbott Medtronic LivaNova PLC Boston Scientific Corporation CryoLife, Inc. Micro Interventional Devices, Inc. (shrink)

Global Women's Health Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- The global women’s health market size was valued at USD 35.02 billion in 2019 and is projected to reach USD 41.05 billion by 2027, exhibiting a CAGR of 3.2% during the forecast period. -/- Drivers & Restraints -/- The global women's health market size stood at USD 35.02 Billion (...) in 2019 and is projected to reach USD 41.05 Billion by 2027, exhibiting at a CAGR of 3.2% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Women's Health Market report. -/- This report focuses on Women's Health Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Women's Health Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Women's Health Market research report: -/- Bayer AG (Leverkusen, Germany) Pfizer Inc. (New York, United States) Amgen Inc. (California, United States) Novartis AG (Basel, Switzerland) Merck & Co., Inc. (New Jersey, United States) Eli Lilly and Company (Indiana, United States) LUPIN (Mumbai, India) AstraZeneca (Cambridge, United Kingdom) Agile Therapeutics (New Jersey, United States) . (shrink)

Contributed papers presented at a seminar organized by Department of Philosophy, Budge Budge College.

Reasoning about concurrent programs involves representing the information that concurrent processes manipulate disjoint portions of memory. In sophisticated applications, the division of memory between processes is not static. Through operations, processes can exchange the implied ownership of memory cells. In addition, processes can also share ownership of cells in a controlled fashion as long as they perform operations that do not interfere, e.g., they can concurrently read shared cells. Thus the traditional paradigm of distributed computing based on locations is replaced (...) by a paradigm of concurrent computing which is more tightly based on program structure. Concurrent Separation Logic with Permissions, developed by O’Hearn, Bornat et al., is able to represent sophisticated transfer of ownership and permissions between processes. We demonstrate how these ideas can be used to reason about fine-grained concurrent programs which do not employ explicit synchronization operations to control interference but cooperatively manipulate memory cells so that interference is avoided. Reasoning about such programs is challenging and appropriate logical tools are necessary to carry out the reasoning in a reliable fashion. We argue that Concurrent Separation Logic with Permissions provides such tools. We illustrate the logical techniques by presenting the proof of a concurrent garbage collector originally studied by Dijkstra et al., and extended by Lamport to handle multiple user processes. (shrink)

Students display resistance in the classroom in numerous ways, often in the form of academic misconduct. Some argue that resistance can reflect cleverness and creativity, rather than apathy. This investigation aimed to develop a psychometric tool to examine classroom resistance as well as identify individual and situational determinants of the same. Data from 853 participants was collected on measures of resistance behaviors in educational contexts and their environmental contributors, creativity, personality, and deception. Further, participants indicated their frequency of resistance across (...) two time periods: kindergarten through middle school, and high school through college. Exploratory and confirmatory factor analyses identified a robust three-factor structure for the Classroom Resistance Scale, comprising Test-Oriented Cheating, Blatant Academic Dishonesty, and Unethical Shortcuts. The person-situation analysis indicated that students who engaged in resistance shared some consistent characteristics: they were more likely to be closed to new experiences, unimaginative, more extraverted, and highly influenced by their peers. Moreover, the frequency of classroom resistance increased in higher grades as compared to lower ones. Implications of spillover effects of academic dishonesty into the workplace are discussed, in addition to suggestions for future research. (shrink)

Global Cancer Diagnostics Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Cancer diagnostic services are useful in recognizing and distinguishing numerous types of cancer. The demand for this service is poised to surge over the coming years with an escalation of the cancer. By 2050, the number of new cancer cases across the globe is set to touch 35 million, (...) depicting a 77% rise from 20 million in 2022, cites the World Health Organization. -/- Drivers & Restraints -/- The global cancer diagnostics market size was valued at USD 15.13 billion in 2023. The market is slated to expand from USD 16.12 billion in 2024 to USD 31.00 billion by 2032, exhibiting a CAGR of 8.5% during the projection period. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Cancer Diagnostics Market report. -/- This report focuses on Cancer Diagnostics Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cancer Diagnostics Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Cancer Diagnostics Market research report: -/- Hoffmann-La Roche Ltd (Switzerland) Thermo Fisher Scientific Inc. (U.S.) Abbott (U.S.) Illumina, Inc. (U.S.) GE Healthcare (U.S.) BD (U.S.) bioMérieux SA (France) Myriad Genetics, Inc (U.S.) Bio-Rad Laboratories, Inc. (U.S.) QIAGEN (Germany). (shrink)

Integrates the seemingly diverse studies of Newtonian physics, quantum mechanics, astrophysics, and molecular biology to explain the timeless philosophies of the ages." Includes biographical profiles of several scientists or philosophers who contributed to human understanding of these realities.

In a bid to curb the spread of COVID-19 in 2020, several countries implemented lockdown procedures to varying degrees. This article sought to examine the extent to which country-level strictness, as measured by the Government Response Stringency Index, moderated the relationship between certain cultural dimensions and estimates of national innovation. Data on 84 countries were collated for Hofstede’s cultural dimensions, and from the Global Innovation Index. Owing to the robust relationships between innovation and the dimensions of uncertainty avoidance, power distance, (...) and individualism, these were used in moderation analyses. In general, power distance was inversely related to innovation, whereas individualism was directly related to it. Results indicated that collectivist and high power distance countries showed lower innovation, irrespective of levels of government stringency as a response to COVID-19. On the other hand, among individualistic and low power distance countries, lower innovation was associated with increased stringency. Higher innovation was observed when such countries had a less severe government response. The dimension of uncertainty avoidance was not significantly associated with innovation at the country level. The implications of lockdowns on general innovation, its inputs, and outputs are discussed in the context of cultural dimensions and country-level policies. (shrink)

Global Biopharmaceuticals Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Biopharmaceuticals are complex medicines extracted or semisynthesized from biological sources using biotechnological methods. They can be sugars, proteins, nucleic acids, living cells, or tissues used for therapeutic or in vivo diagnostic purposes and are produced by means other than direct extraction from a native or non-engineered biological source. -/- Drivers (...) & Restraints -/- The global biopharmaceuticals market size stood at USD 470.80 Billion in 2023 and is projected to reach USD 799.76 Billion by 2030, exhibiting at a CAGR of 7.9% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Biopharmaceuticals Market report. -/- This report focuses on Biopharmaceuticals Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Biopharmaceuticals Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. (shrink)

This article claims that, despite their critical-political stances, three current and influential theoretical frameworks – intersectionality, decoloniality, and ‘Indigenous localism’ – unconsciously accept global capitalism. The article focuses on the work of Crenshaw, Mignolo, Coulthard, and Tuck and Yang, respectively, to argue that, by ascribing to identity politics (intersectionality), a pluriversal politics of authenticity (decoloniality), and a decentralized ‘incommensurability’ (Indigenous localism), each engages in the culturalization and/or localization of politics – one that disavows the dimension of political economy, and because (...) of that, one that conforms well with, and poses no threat to, capitalist liberal globalization. The article concludes by reflecting on what such disavowal says about our late capitalist times, as well as the potentialities and perils of a contemporary subaltern anti-capitalist politics. (shrink)

Creativity and Morality summarizes and integrates research on creativity used to achieve bad or immoral ends. The book includes the use of deception, novel ideas to commit wrongdoings across contexts, including in organizations, the classroom and terrorism. Morality is discussed from an individual perspective and relative to broader sociocultural norms that allow people to believe actions are justified. Chapters explore this research from an interdisciplinary perspective, including from psychology, philosophy, media studies, aesthetics and ethics. Summarizes research on creativity used for (...) immoral purposes Identifies individual and sociocultural perspectives on morality Explores creativity in business, education, design and criminal behavior Includes research from psychology, philosophy, ethics, and more. (shrink)

This book claims that there is a negativity at the core of all social articulations that provides the basis for a universal politics. Drawing principally on the work of Slavoj Žižek, the book suggests that the social is punctured by an impossibility-an incompletion-which rather than serving as a barrier to politics, lays a foundation for shared struggle. The book thus argues for a negative universality, rooted not in a positive element (e.g., identity-based politics) but a discordant one, so that under (...) our current global capitalist system, solidarity is to be forged on the basis of social antagonism (i.e., shared experiences of exploitation and marginalization). Such a conception of shared struggle avoids the trap of both a neocolonial universalism (e.g., the rights of white men parading as universal rights) and the narrow particularism of identity-based politics. Most importantly, it foregrounds the struggles of the systematically dispossessed and excluded (the permanently unemployed, migrants, refugees, sweatshop laborers, etc.), who stand as symptom of our global capitalist order. The book compares "negative universality" with four competing contemporary versions of universalism-conservative, liberal, postcolonial, and Marxist. It also brings "negative universality" into dialogue with present-day critics of universalism-postmodernists, post-Marxists, queer theorists, decolonial pluriversalists, and new materialists. Finally, it examines what a universal politics might look like today in the context of such key global sites of struggle as climate change, the refugee crisis, the Palestinian question, Black Lives Matter, #MeToo, Political Islam, workers' struggles, the Bolivian state under Morales, the European Union, and COVID-19. (shrink)

Global Biopharmaceuticals Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- Biopharmaceuticals are complex medicines extracted or semisynthesized from biological sources using biotechnological methods. They can be sugars, proteins, nucleic acids, living cells, or tissues used for therapeutic or in vivo diagnostic purposes and are produced by means other than direct (...) extraction from a native or non-engineered biological source. -/- Drivers & Restraints -/- The global biopharmaceuticals market size stood at USD 470.80 Billion in 2023 and is projected to reach USD 799.76 Billion by 2030, exhibiting at a CAGR of 7.9% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Biopharmaceuticals Market report. -/- This report focuses on Biopharmaceuticals Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Biopharmaceuticals Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Biopharmaceuticals Market research report: -/- Pfizer Inc. (U.S.) AbbVie Inc. (U.S.) Bristol-Myers Squibb Company (U.S.) Johnson & Johnson Services, Inc. (U.S.) Bayer AG (Germany) Lilly (U.S.) Sanofi (France) Merck & Co., Inc. (U.S.) F. Hoffmann-La Roche Ltd. (Switzerland) Novartis AG (Switzerland) GSK plc (U.K.) Takeda Pharmaceutical Company Limited. (Japan). (shrink)

Global Digital Health Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- The global digital health market size was valued at USD 548.08 billion in 2021 and is projected to grow from USD 742.72 billion in 2022 to USD 4,547.70 billion by 2029, exhibiting a CAGR of 29.5% during the forecast (...) period. Based on our analysis, the global market exhibited a higher growth of 81.2% in 2020 compared to 2019. The global COVID-19 pandemic has been unprecedented and staggering, with digital health experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. -/- Drivers & Restraints -/- The global digital health market size stood at USD 452.79 Billion in 2023 and is projected to reach USD 1,965.30 Billion by 2030, exhibiting at a CAGR of 23.3% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Digital Health Market report. -/- This report focuses on Digital Health Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Digital Health Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Digital Health Market research report: -/- General Electric Company (U.S.) Koninklijke Philips N.V. (Netherlands) Allscripts Healthcare, LLC (U.S.) Cerner Corporation (U.S.) Epic Systems Corporation (U.S.) McKesson Corporation (U.S.) Medical Information Technology, Inc. (U.S.) Siemens Healthcare GmbH (Germany) Boston Scientific Corporation (U.S.) FUJIFILM Holdings Corporation (Japan) Medtronic (Ireland) IBM (U.S.) Validic (U.S.). (shrink)

Global Microfluidic Devices Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Methods of performing experiments easily, cheaply, and speedily, as well as in a highly sensitive and throughput manner, are desirable for many scientific endeavors and commercial applications. To achieve this, the USA introduced the microarray and microfluidic technologies that are beneficial for the discovery of new drugs and analysis (...) of biological systems. -/- Drivers & Restraints -/- The global microfluidic devices market size stood at USD 5.14 Billion in 2018 and is projected to reach USD 22.65 Billion by 2026, exhibiting at a CAGR of 20.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Microfluidic Devices Market report. -/- This report focuses on Microfluidic Devices Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Microfluidic Devices Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Microfluidic Devices Market research report: -/- uFluidix Perkin Elmer Fluidigm Blacktrace Holdings Ltd. (Dolomite Microfluidic) Micronit BioFluidix GmbH‎ Fluigent ALine, Inc. Philips Other prominent players. (shrink)

Global Medical Robotic Systems Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- Robots used in the medical industry, ranging for various applications surgical interventions to rehabilitation are known as medical robots. The ever increasing efficiency of these robots in performing tasks which include surgeries have been pivotal in the rapid (...) adoption of these robots in the medical industry. -/- Drivers & Restraints -/- The global medical robotic systems market size stood at USD 2,257.8 Million in 2018 and is projected to reach USD 10,710.6 Million in 2026, exhibiting at a CAGR of 21.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Medical Robotic Systems Market report. -/- This report focuses on Medical Robotic Systems Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Robotic Systems Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Medical Robotic Systems Market research report: -/- Ekso Bionics Intuitive Surgical Inc. Medtronic Stryker CYBERDYNE INC. BIONIK Smith & Nephew Zimmer Biomet Other Prominent Players. (shrink)

After China, India has the most skewed sex ratio at birth. These two Asian countries account for about 90 to 95% of the estimated 1.2 to 1.5 million missing female births annually, worldwide, due to gender-biased sex selection. To understand this extreme discrimination against girls, this article examines the gendered biopolitics embedded in population policies, new sex selection technologies, and in the social reproduction of patriarchal society. The ethical consequences of advanced reproductive technologies, which remove the moral turpitude around gender-based (...) sex selection by reformulating it into a “modern”, “scientific” endeavour, facilitating the rise of “missing girls”, make this an issue of gender justice, as noted by the World Population Report 2020. This article argues that unpacking gendered biopolitics within the household is crucial to understanding the reproduction of son preference and daughter aversion since it is here that reproduction and parenthood are subjected to biopolitical governance. We discuss how “biosocial” strategies of the household aimed at producing the “desired” and “right” family of more sons at the cost of daughters are operationalized through women’s bodies with a view to family mobility. While women and girls continue to bear the burden and costs of social reproduction that lie at the heart of the patriarchal capitalist system of accumulation, a perusal of more recent studies suggests the beginning of an equalizing trend of parental investments, especially in the health and education of daughters who are “allowed” to be born. We suggest that familial enhancement of girls’ human capital can help as a means of developing girls’ capabilities and agency, enhancing their power in the biopolitics of the family and increasing their “bio-value” in parents’ eyes. (shrink)

There is a growing need to identify what really can converge classroom learning to the real-life practising of ethical principles. We examine if the effectiveness of ethics education can be improved through meditation-based mindfulness intervention. Our baseline experiment is a procedurally modified version of the anagram exercise (Ruedy and Schweitzer 2010) for measuring unethical behaviour. We introduce a brief meditation intervention to induce instant mindfulness. Our findings indicate substantive evidence confirming the positive effect of the state of mindfulness on ethical (...) behaviour. Subjects in the meditation group engage in more low-level cheating compared to the control group who cheated more severely. Gender and academic grade do not influence ethical behaviour. Mindfulness fosters composure, mental poise, and a conducive environment for upholding ethical values, as indicated by a lower incidence of cheating in our study. We propose to promote a learning environment with mindfulness intervention in educational programmes. (shrink)

Frequency selective surface -based intelligent spatial filters are capturing the eyes of the researchers by offering a dynamic behavior when exposed to the electromagnetic radiations. In this manuscript, a concept of creating complementary structures which stems from Babinet’s principle is illustrated. A hybrid complementary pair of FSS comprising double square loop FSS and double square slot FSS on either side of the dielectric substrate is proposed. DSLFSS offers band-pass behavior and can be placed as a superstrate, whereas DSSFSS behaves as (...) a band-stop intelligent spatial filter that blocks the radiations falling on it, thus making them applicable for use as a substrate. The technique utilized for analyzing DSLFSS and DSSFSS structures is based on the equivalent circuit modeling and transmission line methodology. The CPFSS structure offers the design simplicity, hence, suitable for placing them with the printed patch antenna radiators in wireless networking devices operating in sub-6 GHz 5G spectrum. DSLFSS offers band-pass behavior ranging from 2.99 to 5.56 GHz, whereas DSSFSS offers band-stop behavior ranging from 2.85 to 5.42 GHz covering all n77, n78, and n79 bands of FR1 spectrum of sub-6 GHz 5G range. The passband and the stopband offered by the two structures of CPFSS geometry are stable to oblique angles of incidence and the proposed design also offers polarization-independent behavior. The thickness of the dielectric region existing within the pair of designed structures is critical for the location of the passbands and the stopbands. The impact of the overall thickness of the dielectric substrate on the passbands and stopbands is also reported in this article. (shrink)

It is universally accepted that genetic control over basic aspects of cell and molecular biology is the primary organizing principle in development and homeostasis of living systems. However, instances do exist where important aspects of biological order arise without explicit genetic instruction, emerging instead from simple physical principles, stochastic processes, or the complex self‐organizing interaction between random and seemingly unrelated parts. Being mostly resistant to direct genetic dissection, the analysis of such emergent processes falls into a grey area between mathematics, (...) physics and molecular cell biology and therefore remains very poorly understood. We recently proposed a mathematical model predicting the emergence of a specific non‐Gaussian distribution of polygonal cell shapes from the stochastic cell division process in epithelial cell sheets; this cell shape distribution appears to be conserved across a diverse set of animals and plants.1 The use of such topological models to study the process of cellular morphogenesis has a long history, starting almost a century ago, and many insights from those original works influence current experimental studies. Here we review current and past literature on this topic while exploring some new ideas on the origins and implications of topological order in proliferating epithelia. BioEssays 30:260–266, 2008. © 2008 Wiley Periodicals, Inc. (shrink)

The possible differential effects of ABO blood group materno-paternal (fetal) incompatibility on completed reproductive performance were investigated on a sample of 100 couples (100 fathers and 100 mothers) from three villages in the Jind district of Haryana state, India. The average number of live births per mating couple was slightly higher for the incompatible matings (5·32) than the compatible ones (5·05). This advantage was offset by higher postnatal mortality in the former. Consequently, the average number of living children in the (...) compatible matings (4·64) was higher than in the incompatible ones (4·18). With reference to individual ABO matings, the index of relative fertility (Irf) was the highest in A×AB followed by B×A type of incompatible matings. No decrease in live births in O×A and O×B incompatible matings was observed compared with their reciprocal compatible ones, i.e. A×O and B×O matings, as has been hypothesized in previous studies. The total pregnancy wastage was substantially higher in ABO-incompatible matings (24·59%) than compatible matings (8·45%). About 71% of the postnatal deaths took place within one year of the birth in the case of incompatible matings compared with 50% in the case of compatible matings. The study supports the hypothesis that selection is operative at the ABO locus as revealed by the measures of selection intensity. The loss of fitness in the present sample was associated with differential mortality. There were no differences in the proportions of average number of male live births in the compatible (0·55) and incompatible matings (0·58). However, in the individual mating types, there was some evidence of higher or lower proportions of male live births. (shrink)

SummaryAggarwal Baniyas were found to have a high prevalence of high blood pressure. Genetic and environmental influences may be implicated for this risk factor of cardiovascular disease. The aim of this study was to investigate the potential for common genetic and environmental influences on blood pressure measures ). The population-based sample was comprised of 309 Aggarwal Baniya families, including 1214 individuals from New Delhi, India. The prevalence of obesity in this community was found to be high. Correlation and heritability were (...) estimated. Most sibling–sibling correlations were larger than the parent–offspring correlations, and all parent–offspring and sibling–sibling correlations were larger than the corresponding spouse correlation. The maximum heritability was estimated as 44.6% for SBP and 62.8% for DBP. The lack of a significant spouse correlation is consistent with little or no influence of the common familial environment. However, the high heritability estimate for both SBP and DBPs reinforces the importance of the non-shared environmental effect. (shrink)

Seed development in this paper has been classified into the three landmark stages of cell division, organ initiation and maturation, based on morphological changes, and the available literature. The entire process proceeds at the behest of an interplay of various specific and general transcription factors (TFs). Monocots and dicots utilize overlapping, as well as distinct, TF networks during the process of seed development. The known TFs in rice and Arabidopsis have been chronologically categorized into the three stages. The main regulators (...) of seed development contain B3 or HAP3 domains. These interact with bZIP and AP2 TFs. Other TFs that play an indispensable role during the process contain homeobox‐, NAC‐, MYB‐, or ARF‐domains. This paper is a comprehensive analysis of the TFs essential for seed development and their interactions. An understanding of this interplay will not only help unravel an integrated developmental process, but will also pave the way for biotechnological applications. (shrink)